Feb 28 โ€ข 15:45 UTC ๐Ÿ‡ฆ๐Ÿ‡ท Argentina Clarin (ES)

US-Iran: military analysts warn that ending the conflict will be harder than starting it

Military analysts suggest that the recent US and Israeli military actions against Iran could have severe regional repercussions and significant global economic impacts, with the assertion that the US may not have genuinely attempted to negotiate with Tehran.

The recent military action by the United States and Israel against Iran is expected to escalate into a conflict with far-reaching regional effects and critical implications for the global economy, according to experts consulted by Clarรญn. They argue that the White House's negotiation efforts with Tehran were not made in good faith, as the goal appears to be dismantling Iran's political and military power rather than simply deactivating its nuclear arsenal. This assessment is rooted in the belief that the complexity of resolving such a conflict far exceeds that of initiating it.

Experts agree that achieving a resolution will be significantly more challenging than commencing military engagements, emphasizing the necessity for the United States to have ground troops deployed to meet its objectives effectively. Alex Crowther, a senior researcher at the Center for European Policy Analysis in Washington, highlights two critical failures in the US approach. First, history shows that no nation has ever surrendered solely due to an aerial campaign. Secondly, the former president Trump expressed little interest in pursuing a land war against Iran, indicating a potentially flawed strategy in the US's handling of the situation.

These insights reflect a growing concern among military analysts regarding the potential for a protracted conflict that could destabilize the region and disrupt global markets. With escalating tension, there is a fear that without a strategic and well-considered response, the conflict could spiral out of control, leading to broader implications for international relations and economic stability.

๐Ÿ“ก Similar Coverage